PM
PFE icon

Prosight Management’s Pfizer PFE Stock Holding History

Prosight Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
+135,366
New +$3.54M 0.56% 26
2024
Q2 		– Sell
-215,000
Closed -$5.97M – 55
2024
Q1 		$5.97M Buy
+215,000
New +$5.97M 1.66% 18

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prosight Management's PFE Position: Q2 2026 in Review

Prosight Management opened a new position in Pfizer (PFE) in Q2 2026: 135,366 shares worth $3.26M. The stake represents 0.56% of the portfolio and ranks #26 among its holdings. This is a return to the name: Prosight Management previously reported a position in PFE as recently as Q1 2024.

Prosight Management first reported a position in PFE in Q1 2024 and has held it in 2 quarters since. The position peaked at $5.97M in Q1 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prosight Management held 135,366 shares of Pfizer worth $3.26M as of Q2 2026.
  • Pfizer was a new Prosight Management position in Q2 2026.
  • Pfizer made up 0.56% of Prosight Management's portfolio in Q2 2026, its #26 holding.
  • Prosight Management first reported a position in Pfizer in Q1 2024 and has held it in 2 quarters since.
  • Prosight Management's Pfizer position peaked at $5.97M in Q1 2024.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.